iBet uBet web content aggregator. Adding the entire web to your favor.
iBet uBet web content aggregator. Adding the entire web to your favor.



Link to original content: https://pubmed.ncbi.nlm.nih.gov/25435666
Gene doping in sport - perspectives and risks - PubMed Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Dec;31(4):251-9.
doi: 10.5604/20831862.1120931. Epub 2014 Sep 12.

Gene doping in sport - perspectives and risks

E Brzeziańska  1 , D Domańska  1 , A Jegier  2
Affiliations

Gene doping in sport - perspectives and risks

E Brzeziańska et al. Biol Sport. 2014 Dec.

Abstract

In the past few years considerable progress regarding the knowledge of the human genome map has been achieved. As a result, attempts to use gene therapy in patients' management are more and more often undertaken. The aim of gene therapy is to replace defective genes in vivo and/or to promote the long-term endogenous synthesis of deficient protein. In vitro studies improve the production of human recombinant proteins, such as insulin (INS), growth hormone (GH), insulin-like growth factor-1 (IGF-1) and erythropoietin (EPO), which could have therapeutic application. Unfortunately, genetic methods developed for therapeutic purposes are increasingly being used in competitive sports. Some new substances (e.g., antibodies against myostatin or myostatin blockers) might be used in gene doping in athletes. The use of these substances may cause an increase of body weight and muscle mass and a significant improvement of muscle strength. Although it is proven that uncontrolled manipulation of genetic material and/or the introduction of recombinant proteins may be associated with health risks, athletes are increasingly turning to banned gene doping. At the same time, anti-doping research is undertaken in many laboratories around the world to try to develop and refine ever newer techniques for gene doping detection in sport. Thanks to the World Anti-Doping Agency (WADA) and other sports organizations there is a hope for real protection of athletes from adverse health effects of gene doping, which at the same time gives a chance to sustain the idea of fair play in sport.

Keywords: WADA; gene doping; methods of gene doping; methods of proteomic profiling; sport.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Unal M, Ozer Unal D. Gene doping in sports. Sports Med. 2004;34:357–62. - PubMed
    1. DeFrancesco L. The faking of champions. Nat Biotechnol. 2004;22:1069–71. - PubMed
    1. Azzazy HM, Mansour MM, Christenson RH. Doping in the recombinant era: strategies and counterstrategies. Clin Biochem. 2005;38:959–65. - PubMed
    1. Haisma HJ, de Hon O. Gene doping. Int J Sports Med. 2006;27:257–66. - PubMed
    1. Azzazy HM, Mansour MM. Rogue athletes and recombinant DNA technology: challenges for doping control. Analyst. 2007;132:951–57. - PubMed

LinkOut - more resources